Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
J Biotechnol 188:112121
This includes people with kidney and liver disease, those with diseases related to the blood, and women who are pregnant
If you experience any adverse effects, reduce the frequency or consult a dermatologist
Most common adverse events at all doses: Nausea (15-30%, dose-related) Vomiting (5-15%) Decreased appetite (~20%) Constipation (5-12%) Cagrilintide-specific notes: A 2025 Bayesian network meta-analysis of incretin-based therapies reported cagrilintide had one of the lowest GI odds ratios across the studied compound class
US$ 24.51
US$ 21.30
US$ 20.52
US$ 22.91
